New York City Pharmaceutical Society
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 185,652 | 240,921 | −55,269 | 15.8 | 0% |
| 2012 | 166,257 | 263,156 | −96,899 | 10.1 | 0% |
| 2013 | 195,186 | 216,080 | −20,894 | 11.2 | 0% |
| 2014 | 139,979 | 175,939 | −35,960 | 11.3 | 0% |
| 2015 | 312,740 | 127,779 | 184,961 | 32.9 | 0% |
| 2016 | 211,408 | 256,073 | −44,665 | 14.3 | 0% |
| 2017 | 199,633 | 140,330 | 59,303 | 36.4 | 0% |
| 2018 | 633,413 | 213,514 | 419,899 | 47.5 | 0% |
| 2019 | 233,482 | 563,381 | −329,899 | 11.0 | 0% |
| 2020 | 99,519 | 176,039 | −76,520 | 30.1 | 0% |
| 2021 | 117,806 | 116,764 | 1,042 | 45.2 | 0% |
| 2022 | 163,116 | 156,962 | 6,154 | 32.0 | 0% |
| 2023 | 161,414 | 118,887 | 42,527 | 47.1 | 0% |
In its most recent public year (2023), this organization brought in $42,527 more than it spent. Its reserves stood at about 47.1 months of spending, up from 15.8 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
New York City Pharmaceutical Society's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works